Universe Pharmaceuticals (NYSE:UPC) Shares Down 13.3% – Here’s Why

Universe Pharmaceuticals INC (NYSE:UPC)’s stock price fell 13.3% during trading on Friday . The company traded as low as $0.12 and last traded at $0.14. 2,142,620 shares were traded during trading, an increase of 89% from the average session volume of 1,136,569 shares. The stock had previously closed at $0.16.

Universe Pharmaceuticals Stock Down 13.3 %

The company’s 50-day moving average is $7.15 and its two-hundred day moving average is $31.61. The company has a current ratio of 1.63, a quick ratio of 1.46 and a debt-to-equity ratio of 0.08.

Institutional Investors Weigh In On Universe Pharmaceuticals

An institutional investor recently bought a new position in Universe Pharmaceuticals stock. MML Investors Services LLC acquired a new position in Universe Pharmaceuticals INC (NYSE:UPC) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 234,260 shares of the company’s stock, valued at approximately $57,000. MML Investors Services LLC owned approximately 6.46% of Universe Pharmaceuticals at the end of the most recent reporting period. Hedge funds and other institutional investors own 0.18% of the company’s stock.

About Universe Pharmaceuticals

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.